Herpes simplex viruses (HSVs) cause significant morbidity and mortality in humans worldwide. 14 Herpesviruses mediate entry by a multi-component, virus-encoded machinery. Herpesviruses 15 enter cells by endosomal low pH and pH-neutral mechanisms in a cell-specific manner. HSV 16 mediates cell entry via envelope glycoproteins gB, gD, and the heterodimer gH/gL regardless of 17 pH or endocytosis requirements. HSV envelope proteins that function selectively in a given 18 entry pathway have been elusive. Here we demonstrate that gC regulates cell entry and infection 19 by a low pH pathway. Conformational changes in the core herpesviral fusogen gB are critical for 20 membrane fusion. The presence of gC conferred a higher pH threshold to acid-induced antigenic 21 changes in gB. Thus, gC may selectively facilitate low pH entry by regulating conformational 22 changes in the fusion protein gB. We propose that gC modulates the HSV fusion machinery 23 during entry into pathophysiologically relevant cells, such as human epidermal keratinocytes. 24 Keywords: herpesviruses, herpes simplex virus, viral entry, viral glycoproteins 25 26 Importance 27
Introduction 37
Herpesviruses contain multi-component fusion complexes and commandeer diverse entry 38 pathways to enter target cells (1) (2) (3) (4) (5) . Intracellular low pH facilitates entry of several herpesviruses 39 in a cell-specific manner. The prototype alphaherpesvirus, herpes simplex virus, utilizes an 40 acidic endosomal pathway to enter epithelial cells and a pH-independent, direct penetration 41 pathway to enter neuronal cells (6, 7) . The cellular triggers of herpesvirus entry, including 42 intracompartmental pH, remain incompletely understood. HSV entry requires a host cell receptor 43 that binds to viral glycoprotein D, such as HVEM or nectin-1 (8-10), but additional virus-host 44 interactions are likely critical for entry. HSV particles contain at least 12 different virus-encoded 45 envelope proteins. HSV entry into all cells requires gB, gD, and gH/gL. However, the majority 46 of the remaining viral envelope proteins are not thought to be required for entry via either low 47 pH or pH-neutral routes (11). Envelope proteins specific for a given HSV entry pathway have 48 not been identified. 49 HSV envelope glycoproteins gB, gD, and gH/gL are required for entry regardless of a role for 85 intracellular pH in a particular cell type (23, (29) (30) (31) (32) . A survey of seven additional viral envelope 86 proteins indicated that HSV gE, gG, gI, gJ, gM, UL45, or Us9 are dispensable for entry by either 87 low pH or pH-neutral pathways (11) . In this study, we probed the role of gC in low pH entry by 88 employing an HSV-1 KOS strain with the gC gene deleted (HSV-1 ΔgC2-3 or ΔgC) and a 89 repaired version of this virus containing the wildtype gC gene (HSV-1 gC2-3R or gCR) (33) . 90
HSV-1 gC is widely recognized to initiate the viral entry process by attaching to host cell 91 surface glycosaminoglycans, principally heparin sulfate proteoglycans (22, 34) . When gC-92 negative HSV-1 is added to cells, from 20 to 60 min p.i. there is a delay in entry relative to wild 93 type . However, by 90 min p.i., penetration of wild type and gC-null viruses are 94 indistinguishable. HSV-1 lacking gC has a 1 log defect in infectivity (20) . Thus, while gC is 95 dispensable in cell culture, it is important for the viral replicative cycle. 96
The contribution of gC to entry of HSV-1 by a low pH pathway was evaluated. HSV 97 entry into CHO-receptor cells and human keratinocytes proceeds via a low pH endocytic 98 pathway and is well-characterized (Table 1) (6, 7) . The efficiency of ΔgC infection of HVEM cells and primary human keratinocytes (HEKa) was compared to Vero and IMR-32 cells, 100 which support pH-neutral entry via penetration at the plasma membrane (35, 36) . To control for 101 attachment, virus was first added to cells at 4˚C for 1 hr. Following a shift to 37˚C for 6 h, the 102 percentage of viral antigen-positive cells was quantitated. The efficiency of HSV-1gCR entry 103 into each of the four cell types was similar under the conditions tested (Fig. 1A) . In contrast, 104 entry of HSV-1 ΔgC into CHO-HVEM and HEKa cells was ~50% and 35% less efficient than 105
into Vero and IMR-32 cells, respectively (Fig. 1B) . This suggests that gC contributes to low pH 106 entry of HSV. 107 gC contributes to HSV plating efficiency on cells that support a low pH entry pathway.
To confirm and extend this conclusion using an alternate approach, the plating efficiency 109 of HSV-1 ΔgC on different human cell lines was tested. The neuroblastoma SK-N-SH line 110 supports pH-neutral entry of HSV, and HaCaT epidermal keratinocytes support low pH entry 111 (Table 1 ) (6). Identical preparations of HSV-1 ΔgC or gCR were titered. gCR had a similar 112 plating efficiency on SK-N-SH and HaCaT cells ( Fig. 2A) . ΔgC had ~ 1 log lower plating 113 efficiency on HaCaT cells than on SK-N-SH cells (P < 0.01) ( Fig. 2B ). This suggests that gC is 114 specifically important for HSV infectivity of HaCaT cells, which support a low pH entry 115
pathway. 116
To investigate a potential mechanism of gC's involvement in low pH entry, we 117 determined whether ectopic expression of gC restored the infectivity defect of ΔgC in HaCaT 118 cells. SK-N-SH or HaCaT cells were transfected with gC or gD plasmids, and then the plating 119 efficiency of gCR or ΔgC was determined. Cellular expression of gC had no effect on the 120 infectivity of gCR or ΔgC (Fig. 2C, D) . Cell-expressed gD reduces HSV entry and infectivity by 121 competing with virion gD for receptor binding (37). As expected, ectopic expression of gD in 122 either of the cell types reduced infectivity of both gCR and ΔgC (Fig. 2C, D) . These results 123 suggest that gC functions in low pH entry by playing a role other than receptor-binding. 124 gC has no detectable effect on the protein composition of HSV particles. 125
To address the possibility that deletion of gC might affect the incorporation of gB or 126 other viral proteins into the HSV particle, the protein composition of ΔgC was compared to gCR. 127
The absence of gC from virions did not measurably alter the protein composition of particles as 128 measured by SDS-PAGE and protein staining ( Fig. S1A ). Envelope proteins gB, gD, gE, and gH 129 were detected to an equivalent extent in both viruses by Western blot ( Fig S1B) . As expected, 130 gC was not detected in ΔgC virions. The rescuant gCR contains an equivalent amount of gC as 131
HaCaT, and HEKa cells on ΔgC entry using a reporter assay for entry. Ammonium chloride 138 blocks wild type HSV entry into these cells (Table 1) . Ammonium chloride inhibited ΔgC entry 139 into CHO-HVEM, HaCaT, and HEKa cells in a concentration-dependent manner ( Fig. 3D-F) . 140 gCR was similarly inhibited. Together the results suggest that gC contributes to low pH entry 141 (Figs. 1, 2), but is not by itself a viral determinant of selection of the low pH pathway ( Fig. 3) . 142
Ammonium chloride had little to no inhibitory effect on gCR entry into Vero, SK-N-SH or IMR-143 32 cells ( Fig. 3A-C) , which is consistent with pH-neutral entry of wild type HSV in these cells 144 (Table 1) . Entry of ΔgC into Vero, SK-N-SH or IMR-32 cells was similarly unaffected by 145 ammonium chloride ( Fig. 3A-C) , consistent with the notion that gC is dispensable for pH-neutral 146 entry of HSV (38). 147 gC does not contribute to viral attachment under the conditions tested. 148
We assessed the role of gC in HSV-1 attachment to the cell types used in this study. 149 HSV-1 ΔgC or gCR was added to Vero, CHO-HVEM, SK-N-SH, HaCaT, IMR-32, or HEKa 150 cells on ice for 1 hr at 4˚C. Cell-attached HSV-1 was quantitated by qPCR. ΔgC attached to all 151 cells in a manner similar to gCR ( Fig. 4A, B ). CHOpgs745 cells lack a gene required for heparan 152 sulfate biosynthesis. Both viruses exhibited defective attachment to control CHOpgs745 cells 153 ( Fig. 4A, B) . These results suggest that the altered entry and infectivity phenotypes of HSV-1 154
ΔgC cannot be explained by a defect in HSV-1 attachment. gC drives the kinetics of viral penetration from acidic vesicles following intracellular 156 transport of endocytosed HSV. 157
To probe further the role of gC in low pH entry, we monitored the kinetics of intracellular 158 transport of HSV-1 (23). Virus was attached to cells at 4˚C for 1 hr. Cultures were then shifted to 159 37˚C, and at different times post-infection (p.i.), the remaining extracellular virions were 160 inactivated, and cells were lysed. The detection of infectious HSV in cell lysates reflects 161 enveloped HSV present within cellular endocytic compartments. As expected, HSV uptake into 162 vesicles was rapid. At 10 min p.i. in CHO-HVEM cells, there was a peak of intracellular, 163 infectious gCR virus ( Fig. 5A ). Following endocytic uptake, HSV fuses rapidly with the 164 endosomal membrane and releases its capsid into the cytosol (23). This was reflected in the sharp 165 decrease in infectious enveloped gCR recovered by 20 min p.i. (Fig. 5A ). Interestingly, ~50% of 166 infectious, intracellular ΔgC was recovered as late as 40 min p.i., suggesting a delay in HSV 167 fusion with endocytic compartments in the absence of gC ( Fig. 5A ). Analysis of HSV-1 gCR and 168
ΔgC trafficking in HEKa cells yielded results similar to CHO-HVEM cells ( Fig. 5B ). For ΔgC 169 entry into the primary human keratinocytes, there was a ~40 min lag in the intracellular transport 170 and exit of HSV relative to gCR (Fig. 5B ). The results from Figure 5 suggest an important role 171 for gC in the first ~ 20 min of wild type infection. The absence of gC appears to be overcome by 172 ~ 60-120 min p.i., perhaps reflecting why gC is not absolutely essential for low pH entry when 173 longer-term assays are employed. Together, the results suggest that gC mediates rapid 174 intracellular transport of enveloped HSV or may aid in rapid exit of HSV from acidic 175 intracellular vesicles. To further delineate the mechanism underlying gC's role in low pH entry, the effect of gC on 178 low pH-triggered antigenic changes in gB was assessed. The prefusion conformation of gB in the virion envelope undergoes low pH-triggered changes in gB domains I and V (16). These changes 180 are at least partially reversible (16, 39, 40) and are thought to be important for membrane fusion 181 (16, 18, 19) . Domain I of gB contains internal hydrophobic fusion loops that are critical for 182 membrane fusion (41, 42) . ΔgC or gCR virions were treated with a range of mildly acidic pHs 183 (5.0 to 7.3) and blotted immediately to nitrocellulose membrane. Blots were probed at neutral pH 184 with nine monoclonal antibodies (MAbs) to distinct epitopes in gB, and antibody reactivity was 185 detected and quantitated ( Fig. 6 ). A single representative dot blot experiment for one antibody 186 from each of six gB structural domain are shown in Figure S2 . 187
As a reference for comparing ΔgC to gCR, the pH treatment that reduced MAb reactivity 188 by > 50% is indicated ( Fig. 6 ). Domain I MAb H126 had reduced reactivity with gB from gCR 189 that had been acid-treated, but interestingly exhibited little reduction with gB from ΔgC that had 190 been similarly treated ( Fig. 6 ). Using 50% reactivity as a reference point, in the absence of gC, 191 the pH at which changes in the accessibility of the H126 gB epitope occurred was reduced by at 192 least 0.6 pH units ( Fig. 6 ). Similar results were obtained with SS55, another MAb to gB Domain 193 I. For SS55, the pH of gB conformational change in ΔgC was reduced by ~ 0.5 pH units relative 194
to gCR ( Fig. 6 ). We have not previously examined the effect of low pH on gB Domain II. 195 Interestingly, MAbs to domain II, H1781 and H1838, had reduced binding to gCR virions that 196 had been treated with mildly acidic pH, suggesting that gB domain II undergoes pH-triggered 197 conformational change ( Fig. 6 and S2 ). The pH of antigenic change in both of the Domain II 198 epitopes tested was decreased in the absence of gC ( Fig. 6 ). H1838 reactivity with gB in the ΔgC 199 virus was particularly resistant to low pH; treatment with pH 5.0, the lowest tested, still resulted 200 in >50% reactivity, suggesting that gC alters the pH of antigenic change in the H1838 epitope of 201 gB by > 0.7 pH units ( Fig. 6 ). Domain III MAb H1359 had > 50% reduced reactivity only with gB from gCR that had been treated with the most acidic condition tested, pH 5.0. The H1359 203 epitope in HSV-1 ΔgC was more resistant to pH 5.0-treatment relative to gCR. 204
Acidic pH triggers specific, not global, changes in gB conformation, as low pH does not 205 induce changes in the SS10 (domain IV) or H1817 (domain VI) epitopes of gB (16). The SS10 206 and H1817 epitopes in both gCR and ΔgC viruses were not altered by pH (Fig. 6 ). In contrast, 207 gB Domain V from wild type HSV is known to undergo pH-induced conformational change. 208
Following pH 5.0 treatment, Domain V MAbs SS106 and SS144 had a > 50% reduction in 209 reactivity with gB from both gCR and ΔgC, suggesting that gC has an effect on antigenic change 210 in gB domain V ( Fig. 6 ). 211
Control deletion of a viral envelope glycoprotein gene other than gC did not alter the pH 212 of gB antigenic change of a representative epitope (Fig. S3 ). The gB H126 epitope (domain I) in 213
HSV that lacks gE (HSV-1 F-gE/GFP), underwent similar pH-induced changes relative to gB 214 from wild type virus strain F. As a control, the H1817 (domain VI) epitope was unaffected by 215 low pH regardless of the presence of gE ( Fig. S3 ). Together, the results suggest that HSV-1 gC 216 specifically increases the pH threshold of gB conformational change, particularly in Domains I 217 and II. This is consistent with gC facilitating low pH entry and infectivity of HSV ( Fig. 1, 2 , 5), 218 possibly at the level of fusion with an endosomal membrane. Cargo transiting the host 219 lysosome-terminal endocytosis pathway is subjected to decreasing pH, from ~ 6.5 to 4.5. HSV 220 co-localizes with endocytosis markers, but the specific fusion compartment has not been 221 identified (6, 43). Intracellular transport of gC-negative HSV may be delayed because transit to a 222 lower pH compartment is necessary for fusion-associated changes in gB. 223
The pH threshold of reversibility of conformational changes in gB. 224
Reversibility of pH-triggered changes is a hallmark of gB and other class III fusion proteins (16, 225 44, 45) . Pre-fusion and post-fusion forms of class III proteins are proposed to exist in a pH 226 equilibrium that is shifted to the post-fusion state by acidic pH (46). During HSV egress, 227 reversibility may allow gB on progeny virions to avoid nonproductive activation during transport 228 through low-pH secretory vesicles. The pH threshold of initiation of gB conformational change is 229 ~ 6.2 to 6.4 (16). The pH at which acid-treated gB reverts to a pH-neutral conformation is not 230 known. To determine this, virions were treated with pH 5 or maintained at pH 7.3 for 10 min at 231 37˚C. The pH 5-treated samples were increased to different target pHs for 10 min at 37˚C to 232 determine the pH at which reversibility occurs. Samples were then blotted to membrane and 233 probed with representative MAbs to gB (Fig. 7) . Upon treatment with a low pH of 5, there was a 234 reduced reactivity of MAb H126 (domain I) ( Fig. 7A ), H1781 (domain II) ( Fig. 7B ), and SS144 235 (domain V) ( Fig. 7C ), but not H1817 (Domain VI) ( Fig. 7D ). Consistent with Figure 6 , the 236 reduction of gB antibody reactivity with ΔgC was less pronounced. Upon increasing the pH of 237 gCR from 5.0 to 5.6, there was a partial restoration of gB antibody reactivity. Increasing to pH 238 6.2-6.6 resulted in restoration of >80% of the reactivity measured at pH 7.3. This suggests that 239 the pH threshold of reversibility of HSV gB conformational change is between pH 5.0 and 5.6. 240 gB appears to be conformationally labile in this pH range. 241
To assess the influence of gC on the reversibility of gB conformational changes, ΔgC 242 virions were tested for the reversibility of pH-triggered changes in the H126, H1781, SS144, and 243 H1817 epitopes of gB. The results suggest that gC had little influence on the reversibility of gB 244 conformational changes as measured here ( Fig. 7A-C) , rather gC has greater impact on the initial 245 low pH-induced antigenic changes in gB ( Fig. 6 and S2) . 246
Mildly acidic pH changes in gB oligomeric conformation are independent of gC. 247
An independent indicator of pH-induced alterations in gB is a shift to a lower density gB 248 oligomer in response to acid treatment (16). The role of gC in gB oligomeric changes was tested 249
with MAb DL16, which recognizes an oligomer-specific epitope within gB domain V (47).
When either ΔgC or gCR were pretreated with low pH, DL16 reactivity was similarly reduced 251 ( Fig. 8A) , distinguishing the DL16 epitope on gB from the other acid-sensitive epitopes (Fig. 6) . 252
This result signifies acid-triggered change in the oligomeric conformation of gB ( Fig. 8A ) 253 regardless of gC's presence. This outcome was confirmed by an independent measure of gB 254 oligomeric conformation. When HSV is first treated with low pH and then subjected to 1% SDS 255 and native PAGE, the slower migrating, higher molecular weight (HMW) species of gB 256 oligomer disappears, suggesting a change in gB oligomeric conformation (16). Using this 257 approach, the HMW gB oligomer from ΔgC disappeared in a manner similar to gB from the 258 control rescuant virus gCR ( Fig. 8B ). Although gC regulates low-pH induced antigenic changes 259 in gB (Fig. 6) , it does not appear to affect acid-triggered alterations in the gB oligomer. This is 260 consistent with the notion that a similar low pH triggers both antigenic and oligomeric alterations 261 in gB, but these changes are experimentally separable and not identical (18). 262
Since the changes in gB oligomeric conformation did not require gC, we expected that 263 their reversibility would also be gC-independent. This was indeed the case. Acid-induced 264 reduction of reactivity with the oligomer-specific MAb DL16 was partially reversible in both 265
ΔgC and gCR viruses (Fig. 8C) . Likewise, the susceptibility of low-pH treated gB oligomer to 266 disruption by 1% SDS was also reversible, regardless of the presence of gC (Fig. 8D) . Thus, the 267 reversibility of low pH-triggered conformational changes in the gB oligomer is independent of 268 gC. 269
Discussion 270
The mechanisms underlying how herpesviruses traverse distinct cellular entry pathways is 271 paramount to our understanding of these important pathogens. The experiments described here 272 reveal a selective role for HSV-1 gC in low pH entry. HSV-1 gC confers an infectivity 273 advantage in cells that support low pH entry of HSV-1, such as human keratinocytes. There is a 274 lag in the exit of enveloped gC-negative particles from endocytic compartments, which may 275 reflect a role for gC in optimal virus trafficking or low pH fusion. Low pH-triggered antigenic 276 changes in gB domains I, II, and V are thought to be critical for fusion (16, 39, 40, (48) (49) (50) heparin in a cell-free assay, the UL16 tegument protein is rearranged in a gC-dependent manner 285 (52). The role of gC in entry by an acidic endosomal pathway described here is independent of 286 its role in attachment to cell surface heparan sulfate. 287 Viral envelope glycoprotein B (gB) is highly conserved among all subfamilies of the 288
Herpesviridae. Current models of HSV-1 entry posit that 1) gC, and to a lesser extent gB, 289 mediates viral attachment to host cell surface glycosaminoglycans; 2) gD binds to a cognate host 290 cell receptor such as HVEM or nectin-1, resulting in pH-independent conformational change in 291 gD; 3) This is thought to transmit a signal to gH/gL; and 4) culminate in the execution of 292 membrane fusion by gB. Thus, gB, unlike other members of the class III fusion protein family, 293
does not mediate fusion on its own. In addition to pH-triggered changes in gB domains I and V, 294
we show here that acid-induced antigenic changes also occur in domain II ( Fig. 6 and S2) . 295
There is structure-based evidence that gB can exist in multiple conformations. The 296 postfusion structure of gB is known, and distinct, membrane-associated non-postfusion forms, 297 that may reflect the prefusion conformation, have also been resolved (53-55). MAbs that bind 298 specifically to either pre-fusion or post-fusion gB have not been identified. Antibody binding to 299 pre-fusion gB present in virions that are pretreated with low pH does not disappear completely; 300 instead there are decreases in antibody reactivity. Low pH causes gB to assume a non-prefusion 301 form, but is likely not sufficient to shift gB to the post-fusion form. In the absence of gC, the pH 302 threshold for gB conformational changes, particularly in domain I and II is lower by 0.4-0.7 pH 303 units ( Fig 6) . As a comparison, variants and mutants of influenza HA exhibit a ~ 0.2-0.6 shift in 304 the pH of both conformational change and fusion (56, 57). The H126 epitope in the fusion 305 domain of gB might be particularly important for the pH-activation of fusion (18). In the 306 absence of gC, a more acidic pH is required to trigger changes in the accessibility of the H126 307 epitope. 308
The cell tropism of herpesvirus entry and infection is influenced by subfamily-specific 309 viral proteins. EBV gp42 is required for fusion and entry in B cells but not epithelial cells (58-310 62). The HCMV pentamer complex of envelope proteins is necessary for endosomal entry into 311 epithelial and endothelial cells but not for pH-neutral entry into fibroblasts (25, 26, (63) (64) (65) . 312 However, a detailed mechanism underlying EBV gp42 or the HCMV pentamer role in selection 313 of entry pathway is not known. The alphaherpesvirus-specific protein gC is the first HSV 314 envelope protein reported to selectively participate in endocytic entry. Here we suggest that gC is 315 important for HSV-1 epithelial infection but less so for neuronal entry. The results are consistent 316 with a mechanism whereby gC acts to ensure that gB undergoes optimal conformational change 317 to mediate fusion with an appropriate endosomal compartment. 318
The results suggest a functional interaction between gC and gB. Direct interaction 319 between gC and gB has not been detected by co-immunoprecipitation approaches at different 320 pHs (data not shown). Low affinity or transient interactions may not be captured, or gC may 321 exert an indirect effect on gB through another viral or host factor. Physical interactions between 322 HSV-1 gB and gH have also been difficult to detect, despite demonstration of functional 323 interactions (14, 15, 66) . We propose a model whereby gC aids gB, and together with gD and 324 gH/gL, allows rapid entry of HSV-1 into epithelial cells. supplemented with keratinocyte growth kit (ATCC) and penicillin-streptomycin-amphotericin B 342 solution (ATCC). CHOpgs745 cells (ATCC), which lack a gene required for heparan sulfate 343 biosynthesis, were propagated in Ham's F-12 nutrient mixture supplemented with 10% FBS. 344
HSV-1 strain KOS and all viruses in this study were propagated and titered on Vero cells. HSV-345 replaced by lacZ (33); this virus is considered a gC-negative HSV-1. HSV-1 (KOS) gC2-3Rev 347 virus or gCR is a recombinant in which HSV-1 (KOS) ΔgC2-3 was rescued by insertion of the 348 wild-type gC gene (33). Both viruses were obtained from C. Brandt, University of Wisconsin, 349
Madison. The viral genomes have not been sequenced. However, HSV-1 gCR and the parental 350 KOS are indistinguishable in terms of specific infectivity, cell attachment, heparan sulfate 351 binding, and infectivity. Their genomes are similar as measured by restriction enzyme analysis 352
and Southern blotting (33). In addition, the phenotypes attributed to HSV-1 gCR in this study, 353 are similar to those previously reported for HSV-1 wild type strain KOS (6, 7, 16, 18, 23, 68, 354 69) . HSV-1 F-gE/GFP lacks the gE gene (70) 
Immunofluorescence assay of HSV entry and infectivity 364
Equivalent amounts of HSV-1 ΔgC or gCR were added to cells grown on coverslips in 24-well 365 plates in triplicate. Cells were incubated at 4 0 C for 1 hr then washed twice with cold PBS. 366
Cultures were then shifted to 37 0 C for 6 hr then fixed with 100% ice-cold methanol. Primary 367 antibody to HSV-1 ICP4 was then added, followed by Alexa Fluor-488-labeled secondary 368 antibody. Nuclei were counterstained with 12.5 ng/ml DAPI. Approximately 500 cells per well 369 were counted and scored for successful infection.
HSV-1 plaque assay 371
HSV-1 titers were determined by limiting dilution plaque assay. At 18-20 hr p.i., cells were fixed 372 with ice-cold methanol and acetone (2:1 ratio) for 20 min at -20°C and air-dried. Titers were 373 determined by immunoperoxidase staining with rabbit polyclonal antibody to HSV, HR50 374 (Fitzgerald Industries, Concord, Mass.). 375
Ectopic expression of HSV-1 gC 376
Lipofectamine 3000 (ThermoFisherScientific) was used to transfect cells with plasmids encoding 377 gC (pSH140 obtained from G. Cohen and R. Eisenberg), gD (pPEP99; obtained from P. Spear), 378 or empty vector. At 48 hr post-transfection, cells were infected with HSV-1, and infectivity was 379 measured by plaque assay. 380
SDS-PAGE and Western blotting 381
HSV-1 in Laemmli buffer with 200 mM dithiotheriol was boiled for 5 min. Proteins were 382 separated by SDS-PAGE on Tris-glycine gels (Thermo Fisher Scientific). For protein staining, 383 gels were then fixed and stained with 0.025% Coomasie brilliant blue (J.T. Baker Chemical Co., 384
Philipsburg, NJ), 40% methanol (Baker Chemical), and 10% glacial acetic acid (Baker 385 Chemical), followed by destaining with 30% methanol and 7% glacial acetic acid (69). Gels 386 were dried and imaged with a Gel Doc XR imager (Bio-Rad, Hercules, CA). For Western 387 blotting, following transfer to nitrocellulose, membranes were blocked and incubated with HSV 388 polyclonal antibodies R68 (α-gB), R47 (α-gC) (73), R2 (α-gD) (74), R137 (α-gH), anti-gD 389 monoclonal antibody DL6 (75), which were gifts from Gary Cohen and Roselyn Eisenberg; 390 HSV-1 gE monoclonal antibody H1A054-100 (Virusys); or monoclonal antibody H1A021 to 391 VP5 (Santa Cruz Biotechnology, Dallas, TX). After incubation with horseradish peroxidase-392 conjugated secondary antibodies, enhanced chemiluminescent substrate (Pierce) was added, and 393 membranes were exposed to X-ray film (Kodak).
Effect of ammonium chloride on HSV entry and infectivity 395
Cells grown in 24-well plates were treated with medium containing ammonium chloride for 1 hr 396 at 37°C. Virus was added in the continued presence of agent for 6 h. Medium was then removed 397 and replaced with complete DMEM. At 16 h p.i., plaque assay was performed to measure 398 infectivity. CHO-HVEM cells grown in 96-well plates were treated with medium containing 399 ammonium chloride for 20 min at 37°C. Virus was added (MOI of 5) in the continued presence 400 of agent, and beta-galactosidase activity of cell lysates was measured at 6 h p.i. 401
Attachment of HSV-1 to the cell surface 402
Cells grown in 96-well plates were pre-chilled in carbonate-free, serum-free medium 403 supplemented with 20 mM HEPES and 0.2% bovine serum albumin (binding medium) at 4˚C on 404 ice for 20 min. Approximately 10 6 particles of HSV-1 ΔgC or gCR in binding medium were 405 added to cells at 4 0 C on ice for 1 hr. Cultures were washed twice with ice-cold PBS. Cells were 406 trypsinized, and cell-associated HSV-1 DNA was isolated with the QIAamp DNA Blood Mini 407 Kit (Qiagen) according to the manufacturer's instructions. Attached HSV-1 was quantitated by 408 qPCR as previously described (11, 76) . 409
Intracellular tracking of enveloped, infectious HSV 410
HSV-1 ΔgC or gCR was added to confluent cell monolayers (MOI of 8) on ice at 4 0 C for 2 hr. 411
Cultures were washed with PBS and shifted to 37°C. At the indicated times p.i., extracellular 412 virus was inactivated by adding sodium citrate buffer (pH 3.0) for 1 min at 37°C (7). Monolayers 413 were immediately put on ice and washed with cold PBS. One milliliter of Ham's F12 medium 414 with 20 mM HEPES and 1% FBS was added, and cells were lysed by two cycles of freezing and 415 thawing. Titers of lysates were determined on Vero cells. Each data point is the mean of 416 triplicate samples. 417
Dot blot analysis of HSV-1 gB 418
Extracellular HSV preparations were diluted in serum-free, bicarbonate-free DMEM with 0.2% 419 bovine serum albumin (BSA) and 5 mM each of HEPES, MES, and sodium succinate. Virions 420 were adjusted with HCl to achieve a range of different pHs from 5.0 to 7.3. Samples were 421 incubated at 37°C for 10 min, and then either blotted directly to nitrocellulose membrane using a 422 Minifold dot blot system (Whatman), or were first neutralized by addition of pretitrated amounts 423 of 0.05 N NaOH (77). Virus-dotted nitrocellulose membranes were blocked, and then incubated 424 with antibodies to gB at neutral pH. After incubation with horseradish peroxidase-conjugated 425 secondary antibodies, enhanced chemiluminescent substrate (Thermo Fisher Scientific) was 426 added, and blots were exposed to X-ray film (Genesee Scientific). Densitometry was performed 427 with ImageJ. 428
Analysis of gB oligomeric structure by PAGE 429
Extracellular preparations of HSV were diluted in the same medium used for dot blot analysis. 430
Virus samples were adjusted to the indicated pHs with pretitrated amounts of 0.05 N HCl for 10 431 min at 37°C. To test for reversibility of conformational change, samples were then neutralized by 432 addition of pretitrated amounts of 0.05 N NaOH for 10 min at 37°C. 1% SDS was then added. 433
Laemmli sample buffer containing 0.2% sodium dodecyl sulfate (SDS) with no reducing agent 434 (78) was added. Samples were not heated, and proteins were resolved by PAGE. After transfer to 435 nitrocellulose, membranes were blocked and incubated with gB monoclonal antibody H1359. 436
After incubation with horseradish peroxidase-conjugated secondary antibody, enhanced 437 chemiluminescent substrate (Thermo Fisher) was added and membranes were exposed to X-ray 438 film (Genesee Scientific). 439
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